MedPath

Post Transplant Study

Completed
Conditions
Kidney Tansplant
Secondary Hyperparathyroidism
Hyperparathyroidism
Registration Number
NCT00395902
Lead Sponsor
Amgen
Brief Summary

Retrospective chart review to gather information on Sensipar patterns of use and effects on biochemical parameters in renal transplant recipients

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Adults >= 18 years old
  • Subjects who have received Sensipar for a duration of at least 3 months, beginning at least 3 months after a kidney transplant. Subjects must have begun Sensipar teatment no later than Februry 28, 2005 at treating physician's discretion.
Exclusion Criteria
  • Subjects who received Sensipar before undergoing a kidney transplant
  • Subjects receiving dialysis post-transplant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath